文献速递焦虑、强迫与应激相关障碍会诊联络精神医学

创伤后应激障碍临床显著改善与2型糖尿病风险的相关性

Association Between Clinically Meaningful Posttraumatic Stress Disorder Improvement and Risk of Type 2 Diabetes.
PubMed 文献 · JAMA Psychiatry · 2019-01-01

这项回顾性队列研究分析了5916名接受PTSD专科治疗的退伍军人医疗记录,其中1598名符合纳入标准。控制混杂因素后,PTSD症状显著改善与2型糖尿病风险降低显著相关(HR 0.51,95%CI 0.26-0.98)。

要点

  • PTSD症状临床显著改善与2型糖尿病风险降低相关
  • PCL评分下降≥20分者2型糖尿病发生率低于无显著改善者
  • 控制混杂后HR为0.51(95%CI 0.26-0.98)

核心结论

  • PTSD症状的临床显著改善与较低的2型糖尿病风险相关。

研究设计与样本

  • 回顾性队列研究,分析2008至2012财年接受PTSD专科治疗的5916名退伍军人医疗记录,随访至2015财年。
  • 纳入标准为至少一次PCL评分≥50,且在随后12个月内、至少8周后有一次PCL评分;索引日期为首次PCL≥50后12个月。
  • 分析样本为1598名患者,平均年龄42.1(SD 13.4)岁,84.3%男性,66.3%白人。

主要发现

  • 控制混杂因素后,PCL评分显著下降者发生2型糖尿病的风险显著低于无显著下降者(HR 0.51,95%CI 0.26-0.98)。

关键数值与推荐

  • 临床显著改善定义为12个月内PCL评分下降≥20分。
  • 主要结局为2至6年随访期间新发2型糖尿病。

临床怎么用

  • PTSD症状的临床显著改善(无论通过治疗或自发改善)可能有助于降低PTSD患者较高的2型糖尿病风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Posttraumatic stress disorder (PTSD) is associated with increased risk of type 2 diabetes (T2D). Improvement in PTSD has been associated with improved self-reported physical health and hypertension; however, there is no literature, to our knowledge, on whether PTSD improvement is associated with T2D risk. OBJECTIVE: To examine whether clinically meaningful PTSD symptom reduction is associated with lower risk of T2D. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study examined Veterans Health Affairs medical record data from 5916 patients who received PTSD specialty care between fiscal years 2008 and 2012 and were followed up through fiscal year 2015. Eligible patients had 1 or more PTSD Checklist (PCL) scores of 50 or higher between fiscal years 2008 and 2012 and a second PCL score within the following 12 months and at least 8 weeks after the first PCL score of 50 or higher. The index date was 12 months after the first PCL score. Patients were free of T2D diagnosis or an antidiabetic medication use for 12 months before the index date and had at least 1 visit after the index date. Data analyses were completed during January 2019. EXPOSURES: Reduction in PCL scores during a 12-month period was used to define patients as those with a clinically meaningful improvement (≥20-point PCL score decrease) and patients with less or no improvement (<20-point PCL score decrease). MAIN OUTCOMES AND MEASURES: Incident T2D diagnosed during a 2- to 6-year follow-up. RESULTS: Medical records from a total of 1598 patients (mean [SD] age, 42.1 [13.4] years; 1347 [84.3%] male; 1060 [66.3%] white) were studied. The age-adjusted cumulative incidence of T2D was 2.6% among patients with a clinically meaningful PCL score decrease and 5.9% among patients without a clinically meaningful PCL score decrease (P = .003). After control for confounding, patients with a clinically meaningful PCL score decrease were significantly less likely to develop T2DM compared with those without a clinically meaningful decrease (hazard ratio, 0.51; 95% CI, 0.26-0.98). CONCLUSIONS AND RELEVANCE: The findings suggest that clinically meaningful reductions in PTSD symptoms are associated with a lower risk of T2D. A decrease in PCL score, whether through treatment or spontaneous improvement, may help mitigate the greater risk of T2D in patients with PTSD.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Scherrer JF, Salas J, Norman SB, et al. Association Between Clinically Meaningful Posttraumatic Stress Disorder Improvement and Risk of Type 2 Diabetes. JAMA Psychiatry. 2019. PMID: 31433443. doi:10.1001/jamapsychiatry.2019.2096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。